Y70 (Rabeprazole Sodium Delayed-Release 20 mg)
Pill with imprint Y70 is Yellow, Round and has been identified as Rabeprazole sodium delayed-release 20 mg. It is supplied by Aurobindo Pharma Limited.
Rabeprazole is used in the treatment of gerd; barrett's esophagus; duodenal ulcer; erosive esophagitis; duodenal ulcer prophylaxis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Y70
Rabeprazole sodium delayed-release
- Imprint:
- Y70
- Strength:
- 20 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Aurobindo Pharma Limited
- National Drug Code (NDC):
- 65862-0721
More about rabeprazole
- Rabeprazole Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 57 Reviews
- Drug class: proton pump inhibitors
Consumer resources
- Rabeprazole
- Rabeprazole Delayed-Release Tablets
- Rabeprazole Sprinkle Capsules
- Rabeprazole (Advanced Reading)
Other brands: Aciphex, Aciphex Sprinkle
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
